Avenir Wellness Solutions (OTCMKTS:CURR) Trading Up 0.4% - What's Next?

Key Points

• CURR shares were up about 0.4% midday, trading as high as $2.28 and last at $2.25 on roughly 92,492 shares — down about 55% from its average daily volume of 207,211.
• The stock's 50‑day and 200‑day moving averages are $1.80 and $1.98 respectively, it has a market cap of $171.19 million and a negative P/E of -2.56, indicating the company is currently unprofitable.
• Avenir Wellness Solutions, via subsidiary The Sera Labs, develops nutraceutical formulations and sells beauty, health/wellness and pet‑care products (brands include Seratopical and Nutri‑Strips) through retail, private‑label and direct‑to‑consumer channels.

Avenir Wellness Solutions, Inc. (OTCMKTS:CURR - ) shares were up 0.4% during mid-day trading on Thursday . The company traded as high as $2.28 and last traded at $2.25. Approximately 92,492 shares changed hands during mid-day trading, a decline of 55% from the average daily volume of 207,211 shares. The stock had previously closed at $2.24.

Avenir Wellness Solutions Price Performance

The business's 50-day moving average price is $1.80 and its two-hundred day moving average price is $1.98. The firm has a market cap of $171.19 million and a price-to-earnings ratio of -2.56.

About Avenir Wellness Solutions

Avenir Wellness Solutions, Inc, through its subsidiary The Sera Labs, Inc, engages in the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve efficacy and enhance wellness. It provides its products in beauty, health and wellness, and pet care categories under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brand names. The company sells its products through drug and grocery chains, convenience stores, and mass retailers. It also offers its products under private label to retailers and multi-level marketers, as well as DTC, via online website orders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.